HomeBUSINESS
BUSINESS

Daiichi Sankyo Pairs Up with German Startup to Develop ADC for Solid Cancer
(Nov.1.2017)

Daiichi Sankyo said on October 30 that it has entered into an option agreement with German biotech startup Glycotope GmbH to develop an antibody drug conjugate (ADC) for the treatment of cancers ...
(LOG IN FOR FULL STORY)

News Calendar